MedTech — Selling, marketing and administrative expenses
Business Segments · Selling, marketing and administrative expensesJohnson & Johnson MedTech — Selling, marketing and administrative expenses decreased by 2.1% to $2.80B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.9%, from $2.72B to $2.80B. Over 2 years (FY 2022 to FY 2024), MedTech — Selling, marketing and administrative expenses shows an upward trend with a 6.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2022
Last reportedQ3 2025
Rolls up toSG&A
How to read this metric
High expenses relative to revenue may indicate heavy investment in market expansion or inefficient administrative overhead.
Detailed definition
Represents the operating expenses incurred to support the sales, marketing, and general administration of the MedTech se...
Peer comparison
Standard operating expense category for business segments.
Metric ID:
jnj_segment_medtech_selling_marketing_and_administrative_expensesHistorical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.38B | $2.38B | $2.38B | $2.38B | $2.62B | $2.62B | $2.62B | $2.62B | $2.58B | $2.67B | $2.72B | $2.84B | $2.66B | $2.86B | $2.80B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +9.8% | +0.0% | +0.0% | +0.0% | -1.4% | +3.4% | +1.9% | +4.1% | -6.3% | +7.8% | -2.1% |
| YoY Change | — | — | — | — | +9.8% | +9.8% | +9.8% | +9.8% | -1.4% | +2.0% | +4.0% | +8.3% | +2.9% | +7.2% | +2.9% |
Range$2.38B – $2.86B
CAGR+4.7%
Avg YoY Growth+5.9%
Median YoY Growth+7.2%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — selling, marketing and administrative expenses?
- Johnson & Johnson (JNJ) reported medtech — selling, marketing and administrative expenses of $2.80B in Q3 2025.
- How has Johnson & Johnson's medtech — selling, marketing and administrative expenses changed year-over-year?
- Johnson & Johnson's medtech — selling, marketing and administrative expenses increased by 2.9% year-over-year, from $2.72B to $2.80B.
- What is the long-term trend for Johnson & Johnson's medtech — selling, marketing and administrative expenses?
- Over 2 years (2022 to 2024), Johnson & Johnson's medtech — selling, marketing and administrative expenses has grown at a 6.5% compound annual growth rate (CAGR), from $9.54B to $10.81B.
- What does medtech — selling, marketing and administrative expenses mean?
- The overhead and selling costs required to run the MedTech business.